Concepedia

Natalia Skobeleva

NS

Statistics

Publications

5

Citations

148

H-Index

5

Active since

2007

Affiliations

Fox Chase Cancer Center(Current)

Synta Pharmaceuticals (United States)

Natalia Skobeleva is an author at Fox Chase Cancer Center specializing in pharmacology, oncology, and medicine.

Publications per year

2007–2016

5

Publications

5

Isoquinolin‐1‐one Inhibitors of the MDM2–p53 Interaction

Ulli Rothweiler, Anna Czarna, Marcin Krajewski et al. · ChemMedChem · 2008 · 55 citations

, , +13

A Novel HSP90 Inhibitor–Drug Conjugate to SN38 Is Highly Effective in Small Cell Lung Cancer

Anna V. Gaponova, Anna S. Nikonova, Alexander Y. Deneka et al. · Clinical Cancer Research · 2016 · 33 citations

, , +16

<i>In vitro</i> and <i>in vivo</i> synergy of MCP compounds with mitogen-activated protein kinase pathway– and microtubule-targeting inhibitors

Natalia Skobeleva, Sanjay Menon, Lutz Weber et al. · Molecular Cancer Therapeutics · 2007 · 29 citations · Full text

, , +17

Re-purposing clinical kinase inhibitors to enhance chemosensitivity by overriding checkpoints

Neil Beeharry, Eugenia Banina, James C. Hittle et al. · Cell Cycle · 2014 · 17 citations · Full text

, , +15

Targeted delivery of chemotherapy using HSP90 inhibitor drug conjugates is highly active against pancreatic cancer models

Egor Bobrov, Natalia Skobeleva, Diana Restifo et al. · Oncotarget · 2016 · 14 citations · Full text

, , +15

1–5 of 5